Hodgkin's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Hodgkin's Disease, including details on causes, cancer, lymphoma, stages, symptoms.

Volume 2 (2005), Issue 3 (March)

1. Perspectives of the management of childhood lymphoma: experience at Tygerberg Hospital, Western Cape, South Africa.
   Transfus Apher Sci, 32(1): 27-31. [Abstract] [Full-text]
2. A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma.
   Biol Blood Marrow Transplant, 11(3): 181-7. [Abstract] [Full-text]
3. Functional humanization of an anti-CD30 Fab fragment for the immunotherapy of Hodgkin's lymphoma using an in vitro evolution approach.
   Protein Eng Des Sel, 17(12): 847-60. [Abstract] [Full-text]
4. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells.
   Clin Cancer Res, 11(4): 1467-73. [Abstract] [Full-text]
5. Efficacy of CT-guided percutaneous needle biopsy in the diagnosis of malignant lymphoma at first presentation.
   Clin Imaging, 29(2): 123-7. [Abstract] [Full-text]
6. Use of 18F-FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusions.
   Br J Haematol, 128(6): 824-9. [Abstract] [Full-text]
7. A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease.
   Bone Marrow Transplant, 35(6): 557-66. [Abstract] [Full-text]
8. 18F-FDG-avid sites mimicking active disease in pediatric Hodgkin's.
   Pediatr Radiol, 35(2): 141-54. [Abstract] [Full-text]
9. Single-cell analysis of loss of heterozygosity at the ATM gene locus in Hodgkin and Reed-Sternberg cells of Hodgkin's lymphoma: ATM loss of heterozygosity is a rare event.
   Int J Cancer, 114(6): 909-16. [Abstract] [Full-text]
10. Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse.
    Ann Oncol, 16(4): 625-33. [Abstract] [Full-text]
11. Glutathione S-transferase P1 genotype and prognosis in Hodgkin's lymphoma.
    Clin Cancer Res, 11(6): 2175-9. [Abstract] [Full-text]
12. Differential expression of activation-induced cytidine deaminase (AID) in nodular lymphocyte-predominant and classical Hodgkin lymphoma.
    J Pathol, 205(5): 541-7. [Abstract] [Full-text]
13. Seasonal variation in the diagnosis of Hodgkin lymphoma in Sweden.
    Int J Cancer, 115(1): 127-30. [Abstract] [Full-text]
14. Alterations of loci encoding PU.1, BOB1, and OCT2 transcription regulators do not correlate with their suppressed expression in Hodgkin lymphoma.
    Cancer Genet Cytogenet, 158(2): 167-71. [Abstract] [Full-text]
15. Simultaneous targeting of IL2 and IL12 to Hodgkin's lymphoma cells enhances activation of resting NK cells and tumor cell lysis.
    Int J Cancer, 115(2): 241-7. [Abstract] [Full-text]

© 2004-2012 Hodgkin's Disease Research Today. All Rights Reserved.